[HTML][HTML] HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

AS Ramcharan, KJ Van Stralen, JD Snoep… - Journal of Thrombosis …, 2009 - Elsevier
Summary Background: Statins [3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA)
reductase inhibitors] and antiplatelet therapy reduce the risk of atherosclerotic disease.
Besides a reduction of lipid levels, statins might also have antithrombotic and anti-
inflammatory properties, and anti-platelet therapy reduces clot formation. We have studied
the risk of venous thrombosis with use of statins, other lipid-lowering medication, and
antiplatelet therapy. Materials and methods: Patients with a first episode of deep vein …